FABP1 and kidney disorder: Itoh et al. measured urinary markers of nephropathy after treatment with esaxerenone, including 8-hydroxydeoxyguanosine, angiotensinogen, β2-MG, L-FABP, and N-acetyl-β-d-glucosaminidase.